Bausch Health (TSX:BHC) Dividends per Share : C$0.00 (TTM As of Mar. 2025)

View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Dividends per Share?

Bausch Health's dividends per share for the three months ended in Mar. 2025 was C$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2025 was C$0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2025 was 0.00. As of today, Bausch Health's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bausch Health was 47.10% per year. The lowest was -42.80% per year. And the median was 5.60% per year.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Bausch Health Dividends per Share Historical Data

The historical data trend for Bausch Health's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Dividends per Share Chart

Bausch Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dividends per Share

Get a 7-Day Free Trial

Bausch Health Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Bausch Health's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch Health's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Bausch Health's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Bausch Health Dividends per Share Calculation

Dividends paid to per common share.

Bausch Health (TSX:BHC) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Bausch Health's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2025 )	/	EPS without NRI (Q: Mar. 2025 )
	=	0	/	-0.183
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Bausch Health Dividends per Share Related Terms

Thank you for viewing the detailed overview of Bausch Health's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

BHC:USA BHC:Mexico BVF:Germany BVF:Germany

Address

2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Executives

Seana Lynne Carson	Senior Officer
Robert Allen Spurr	Senior Officer
Joseph Gordon	Senior Officer
Steven Daniel Miller	Director
Andrew Charles Von Eschenbach	Director
Richard Urbain De Schutter	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Osama Eldessouky	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Amy Wechsler	Director
William Douglas Humphries	Senior Officer
John Paulson	Director
Thomas Ross Sr.	Director
Christina Ackermann	Senior Officer
Joseph Papa	Director, Senior Officer
Paul Herendeen	Senior Officer